Thursday, 02 April 2020

China News

  • Simcere Pharma reports preliminary Q2 results

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2012

    Singapore: Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in...Read more

  • NYSE halts delisting of China Botanic

    China |  News | By BioSpectrum Bureau  | 0 Comment | 08 Mar, 2013

    Singapore: New York Stock Exchange (NYSE) has accepted plan of compliance submitted by China Botanic Pharmaceutical , a developer, manufacturer and distributor of botanical products, bio-p...Read more

  • The world's most advanced biomedical R&D center

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 12 May, 2014

    Bangalore: China Medical City (CMC), also known as Taizhou National Medical Hi-tech Industrial Development Zone, is China's high-tech development zone focusing on biomedical R&D, manufa...Read more

  • 10 challenges for businesses in APAC

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 17 May, 2012

    The Asia Pacific healthcare market is estimated to capture 34.6 percent of the global healthcare market by 2015. Frost & Sullivan says that by 2020, healthcare expenditure in the APAC w...Read more

  • Veredus lab-on-chip leverages on China flu outbreak

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Apr, 2013

    Singapore: Veredus Laboratories has come up with a lab-on-chip application called VereFlu that detects the current subtype of H7N9 (Avian Flu) that is responsible for killing atleast seven ...Read more

  • Simcere sells equity interest in Shanghai Celgen

    China |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jan, 2013

    Singapore: Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded and proprietary pharmaceuticals in China,...Read more

  • Concord Medical reveals Q1 2012 results

    China |  Company results | By BioSpectrum Bureau  | 0 Comment | 22 May, 2012

    Singapore: Concord Medical , a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China, reported ...Read more

  • Big deals: M&As in pharma

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 19 Jun, 2012

    In 2011, the global pharmaceutical industry saw 504 mergers and acquisitions (M&A), with a total transaction value of $90 billion. Furthermore, the number of transactions in the $100 mi...Read more

  • Chinese scientists find MVK mutations linked to skin disorder

    China |  News | By BioSpectrum Bureau  | 0 Comment | 17 Sep, 2012

    Singapore: A Chinese research team, led by Anhui Medical University and BGI, has found the strong genetic evidences of mevalonate kinase gene (MVK) mutations linked to disseminated superfic...Read more

  • PRA expands in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 29 Aug, 2012

    Singapore: PRA, a clinical research organization, has opened a second office in China to accommodate its continued expansion in the country and in the Asia Pacific region. PRA established ...Read more

  • BioSpectrum Asia honors Asia's best in bioscience

    China |  News | By BioSpectrum Bureau  | 0 Comment | 15 Mar, 2013

    Singapore: The fifth BioSpectrum Asia Pacific Awards 2013 were given away at a glittering ceremony at Hotel Fort Canning, Singapore, on March 15, 2013. Industry leaders and heads of compani...Read more

  • Five more H7N9 cases reported in China

    China |  News | By BioSpectrum Bureau  | 0 Comment | 03 Mar, 2014

    Singapore: With the number of H7N9 cases increasing in China, the country has now reported five new cases and one death in the last one week. Hong Kong researchers have also reported genet...Read more

  • Genome of most voracious mustard pest is decoded

    China |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jan, 2013

    Singapore: An international research consortium, led by Fujian Agriculture, Forestry University (FAFU) and Beijing Genomics Institute (BGI), China, has completed the first genome sequence ...Read more

  • What is the revenue size, range of CROs in APAC?

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 18 Sep, 2013

    The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conducted in association with CyberMedia Research (CMR), yet again identifie...Read more

  • Sihuan, NeuroVive to develop heart and brain products

    China |  News | By BioSpectrum Bureau  | 0 Comment | 21 Nov, 2012

    Singapore: Sihuan Pharmaceutical entered into a collaboration agreement with NeuroVive Pharmaceutical to develop two innovative products, CicloMulsion and NeuroSTAT, which are used for the...Read more

  • Generics market to touch $231 bn by 2017: Report

    China |  Analysis | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2012

    Singapore: The global generic pharmaceuticals market is likely to witness strong growth in the next few years owing to the patent expiration of key blockbuster drugs and the judicious cost ...Read more

  • Alibaba to fund pharma information platform

    China |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jan, 2014

    Singapore: Chinese eCommerce giant, Alibaba Group has announced that it would help fund a pharmaceutical information platform being developed by CITIC 21CN Co, a subsidiary of CITIC Group. ...Read more

  • India, China to appeal against EU regulation on API

    China |  News | By BioSpectrum Bureau  | 0 Comment | 10 Aug, 2012

    Bangalore: Following a change in rules for importing active substances into the European Union for medicinal products for human use, India and China are contemplating to take up the matter ...Read more